Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
Robert Bissonnette, Andreas Pinter, Laura K. Ferris, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 6, pp. 510-521
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Preclinical proof of principle for orally delivered Th17 antagonist miniproteins
S. A. Berger, Franziska Seeger, Ta-Yi Yu, et al.
Cell (2024) Vol. 187, Iss. 16, pp. 4305-4317.e18
Open Access | Times Cited: 20
Advances in psoriasis research: From pathogenesis to therapeutics
Dineshwar Sugumaran, Audrey Chee Hui Yong, Johnson Stanslas
Life Sciences (2024) Vol. 355, pp. 122991-122991
Closed Access | Times Cited: 15
The coming of age of cyclic peptide drugs: an update on discovery technologies
S You, Glen J Mcintyre, Toby Passioura
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 8, pp. 961-973
Closed Access | Times Cited: 9
From lead to market: chemical approaches to transform peptides into therapeutics
Caitlin L. Gare, Andrew M. White, Lara R. Malins
Trends in Biochemical Sciences (2025)
Closed Access | Times Cited: 1
Psoriasis — More Progress but More Questions
Joel M. Gelfand
New England Journal of Medicine (2024) Vol. 390, Iss. 6, pp. 561-562
Closed Access | Times Cited: 5
IL23p19 therapies for moderately-to-severely active ulcerative colitis
Newaz Shubidito Ahmed, Christopher Ma
Expert Opinion on Biological Therapy (2025)
Closed Access
Management of Challenging Psoriasis Clinical Scenarios
Linda Stein Gold, Andrew Alexis, Brad Glick, et al.
Dermatology and Therapy (2025)
Open Access
A complete sojourn on nanotechnological advancements and nanocarrier applications in psoriasis management
Rahul Thakur, Aman Kumar, K.K. Aggarwal, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
The ‘inflammazone’ in chronic inflammatory diseases: psoriasis and sarcoidosis
Phei Er Saw, Erwei Song
Trends in Immunology (2025)
Closed Access
A spatial confinement biological heterogeneous cascade nanozyme composite hydrogel combined with nitric oxide gas therapy for enhanced treatment of psoriasis and diabetic wound
Yuying Zhang, Cunpeng Nie, Zishu Wang, et al.
Chemical Engineering Journal (2025), pp. 160629-160629
Closed Access
Therapeutic Advancements in Psoriasis and Psoriatic Arthritis
Robin C. Yi, Maya Akbik, Logan R. Smith, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1312-1312
Open Access
Paradigm Shift in Inflammatory Bowel Disease Management: Precision Medicine, Artificial Intelligence, and Emerging Therapies
Antonio M.� Caballero-Mateos, Guillermo A. Cañadas‐De la Fuente, Beatriz Gros
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1536-1536
Open Access
Post-synthetic Chemical Functionalization of Peptides
Stephanie A. Barros, Rosaura Padilla‐Salinas, Irini Abdiaj
Elsevier eBooks (2025)
Closed Access
Adiponectin receptor agonist adipoRon alleviates imiquimod-induced murine psoriasis
Geng Sun, Haiqian Zhao, Yuan-Yuan Huang, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114568-114568
Closed Access
American Academy of Dermatology Annual Meeting: Orlando, FL, USA, 7-11 March 2025
Kathy A Fraser
American Journal of Clinical Dermatology (2025)
Closed Access
Enhanced Topical Delivery of Methotrexate via Transferosome-Loaded Microneedle Array Patch: Formulation, Optimization, and In Vitro–In Vivo Assessment
Snehal Shinde, Anil Kumar Singh, Vijay R. Chidrawar, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 594-594
Open Access
Pediatric immune-mediated skin diseases: a review of advancements in biologics and JAK inhibitor treatments
Emadodin Darchini‐Maragheh, Anthony Moussa
Drugs & Therapy Perspectives (2025)
Open Access
JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humans
Anne M. Fourie, Xiaoli Cheng, Leon Chang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Therapeutic Advances in Psoriasis: From Biologics to Emerging Oral Small Molecules
Francesco Ferrara, Chiara Verduci, Emanuela Laconi, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 76-76
Open Access | Times Cited: 3
IL-23 inhibition for chronic inflammatory disease
Vipul Jairath, María Laura Acosta Felquer, Raymond J. Cho
The Lancet (2024) Vol. 404, Iss. 10463, pp. 1679-1692
Closed Access | Times Cited: 3
Interleukin-21 and Interleukin-23 levels in familial Mediterranean Fever before and after treatment: the role of cytokines in disease pathogenesis
Mutlu Hızal, Abdurrahman Tufan, Rıdvan Mercan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Accessing diverse bicyclic peptide conformations using 1,2,3-TBMB as a linker
Haritha Krishna Sudhakar, Jackie Tsz Ki Yau, Lisa J. Alcock, et al.
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 30, pp. 6095-6102
Closed Access | Times Cited: 1
Oral Psoriasis Therapies
JaBreia F. James, T. Otto, Julia Gao, et al.
Dermatologic Clinics (2024) Vol. 42, Iss. 3, pp. 357-363
Closed Access | Times Cited: 1
American Academy of Dermatology Annual Meeting: San Diego, CA, USA, 8–12 March 2024
Kathy A Fraser
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 509-512
Closed Access | Times Cited: 1
Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyond
Antonio Portarapillo, Luca Potestio, Nello Tommasino, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 9, pp. 1187-1198
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top